Concepedia

Author

Mikhail Fominykh

Russian Research Institute of Hematology and TransfusiologyORCID

Also Known As

I. N. Subortseva, M S Fominykh, M. Fominykh, M. S Fominykh, M. S. Fominykh, M.S. Fominykh, Mikhail Fominykh, М.С. Фоминых

96

Publications

233

Citations

7

H-Index

21

Concepts

All Affiliations

Russian Research Institute of Hematology and TransfusiologySt Petersburg UniversityNational Medical Research Center for HematologyFirst Pavlov State Medical University of St. PetersburgFederal Almazov North-West Medical Research Centre
MF

About

Mikhail Fominykh is an author at Russian Research Institute of Hematology and Transfusiology specializing in medicine, hematology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

108

2

Health Sciences

2

2

69

3

Cell Biology

2

2

50

4

Immunology

2

2

50

5

Cellular Therapies

1

1

25

Mikhail Fominykh

×

6

Publications

145

Citations

6

H-Index

YearCitations

Long-term treatment-free remission in patients with chronic myeloid leukemia after second-line nilotinib: ENESTop 5-year update

Timothy P. Hughes, Nelma Cristina D. Clementino, Mikhail Fominykh,

Leukemia

2021

44

Transplantation of Mesenchymal Stem Cells in Multiple Sclerosis

Odinak Mm, Mikhail Fominykh, P. V. Kruglyakov

Neuroscience and Behavioral Physiology

2012

25

[Transplantation of mesenchymal stem cells in multiple sclerosis].

Odinak Mm, Novitskiĭ Av, Mikhail Fominykh,

PubMed

2011

25

Clinical Recommendations for the Diagnosis and Treatment of Chronic Myeloid Leukemia

Anna Turkina, A.Yu. Zaritskii, Vasily Shuvaev,

Clinical oncohematology

2017

22

Efficacy of Tyrosine Kinase Inhibitors in Third Line Therapy in Chronic Phase Chronic Myeloid Leukemia

Elza Lomaia, Andrey Zaritskey, Vasily Shuvaev,

Blood

2015

15

Withdrawal Syndrome After Tyrosine Kinase Inhibitor Discontinuation in Patients With Chronic Myeloid Leukemia in the Russian Prospective Study RU-SKI

Ekaterina Chelysheva, Oleg Shukhov, Anastasiya Bykova,

Clinical Lymphoma Myeloma & Leukemia

2020

14

Page 1